Related Experiment Video
Updated: Jul 26, 2026

Contrast Enhanced Vessel Imaging using MicroCT
Published on: January 27, 2011
Comparison of intravenous contrast agents for CT studies in children
M D Cohen1, E Herman, D Herron
1Department of Radiology, Riley Hospital for Children, Indiana University Medical Center, Indianapolis.
Insights
Low osmolarity contrast agents like iohexol and iopamidol are recommended for pediatric CT scans. Meglumine diatrizoate caused significantly more side effects, potentially impacting image quality in children.
Area of Science:
- Radiology
- Pediatric Imaging
- Medical Contrast Agents
Background:
- Intravenous (IV) contrast agents are crucial for CT examinations.
- Traditional ionic contrast agents can cause adverse reactions.
- Minimizing side effects is essential for pediatric patient comfort and image quality.
Purpose of the Study:
- To compare the incidence of side effects of different IV contrast agents in children undergoing CT.
- To evaluate the impact of contrast agent side effects on pediatric CT imaging.
- To determine the optimal contrast agent for pediatric CT examinations.
Main Methods:
- A randomized controlled trial involving 180 pediatric patients undergoing CT.
- Comparison of three IV contrast agents: meglumine diatrizoate (high osmolarity), iohexol (low osmolarity), and iopamidol (low osmolarity).
- Monitoring and recording of all minor side effects experienced by patients.
Main Results:
- Meglumine diatrizoate resulted in a high incidence of minor side effects (85%).
- Iohexol showed a significantly lower incidence of side effects (18%), followed by iopamidol (36%).
- Minor side effects can lead to patient motion and delayed scanning, potentially degrading CT image quality.
Conclusions:
- Low osmolarity contrast agents (iohexol, iopamidol) are associated with fewer side effects in pediatric CT.
- Reducing side effects with appropriate contrast agent selection can improve pediatric CT image quality.
- Low osmolarity agents are recommended for IV use in pediatric CT imaging.
Abstract:
One hundred and eighty children undergoing CT examination were randomly allocated to receive meglumine diatrizoate, iohexol, or iopamidol as their i.v. contrast agent. Minor side effects were detected in 85% of children receiving meglumine diatrizoate, in 18% of those receiving iohexol, and in 36% of those receiving iopamidol. Because many of these minor side effects cause patient motion or delay scanning after contrast medium injection, they potentially degrade image quality. These findings are an indication for the use of low osmolarity contrast agents for i.v. use in pediatric CT imaging.
Related Concept Videos
Radiological Investigation I: X-ray and CT
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Imaging Studies for Cardiovascular System V: CT
Imaging Studies III: Computed Tomography
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Imaging Studies VII: Vascular Imaging

